Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-04-04 249766
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-12 2025-01-17 245496
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-12 2025-01-17 245499
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-05 2025-01-17 244922
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL TABLET 10 MG 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL TABLET 20 MG 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL TABLET 5 MG 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-LOPERAMIDE - TAB 2MG 2MG TABLET Discontinued 2017-03-31 2017-03-31 4930
APO-LORAZEPAM TAB 0.5MG 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM TAB 1MG 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN 25MG TABLET Discontinued 2019-02-01 2019-02-02 74376
APO-LOSARTAN 50MG TABLET Discontinued 2018-09-10 2018-09-15 60987
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600